CRYSTAL FORM OF ACID ADDITION SALT OF PUROPYRIMIDINE COMPOUND
作者： Ha Tae Hee , Jang Sun Young , Oh Hee Sook , Jeon Ji Young , Jung Jae Hyuk
DOI:
关键词:
摘要: One embodiment relates to: a crystal form of an acid addition salt N-(3-(2-(4-(4-methylpiperazine-1-yl)phenylamino)puro[3,2-d]pyrimidine-4-yloxy)phenyl)acrylamide; and pharmaceutical composition comprising same. The can be easily used in the preparation same as active ingredient.
lens.org 参考文章(5)
Antje Margret Wengner, Holger Steuber, Roland Neuhaus, Reinhard Nubbemeyer, Martin Lange, Nicole Schmidt, Andreas Sutter, Holger Siebeneicher, Christian Stegmann, Judith Günther, Ulrich Bothe, Ulf Bömer, Combinations of inhibitors of irak4 with inhibitors of btk ,(2016)
이주연, 김맹섭, 차미영, 조명기, 하태희, 이광옥, 전지영, 곽은주, 강석종, 김미라, 서귀현, Novel fused pyrimidine derivatives for inhibition of tyrosine kinase activity ,(2011)
Jung Jae Hyuk, Ha Tae Hee, Baek Jong Ouk, Kim Hee Cheol, Kwak Eun Joo, Jung Sun Young, 싸이에노피리미딘 화합물의 결정형 ,(2018)
Oh Hee Sook, Ha Tae Hee, Baek Jong Ouk, Kim Hee Cheol, Jang Sun Young, Jeon Ji Young, 싸이에노피리미딘 화합물의 하이드로클로라이드 염의 결정형 ,(2018)